Terms: = Breast cancer AND IL6ST, CDw130, 3572, ENSG00000134352, P40189, IL6R-beta, GP130-RAPS, GP130, CD130
91 results:
1. Immunotherapeutic IL-6R and targeting the MCT-1/IL-6/CXCL7/PD-L1 circuit prevent relapse and metastasis of triple-negative breast cancer.
Haq ATA; Yang PP; Jin C; Shih JH; Chen LM; Tseng HY; Chen YA; Weng YS; Wang LH; Snyder MP; Hsu HL
Theranostics; 2024; 14(5):2167-2189. PubMed ID: 38505617
[No Abstract] [Full Text] [Related]
2. Impact of disulfidptosis-associated clusters on breast cancer survival rates and guiding personalized treatment.
Chen X; Hu G; Yu Q
Front Endocrinol (Lausanne); 2023; 14():1256132. PubMed ID: 38116315
[TBL] [Abstract] [Full Text] [Related]
3. The clinical relevance of OSM in inflammatory diseases: a comprehensive review.
Wolf CL; Pruett C; Lighter D; Jorcyk CL
Front Immunol; 2023; 14():1239732. PubMed ID: 37841259
[TBL] [Abstract] [Full Text] [Related]
4. Construction of a prognostic model for triple-negative breast cancer based on immune-related genes, and associations between the tumor immune microenvironment and immunological therapy.
Zhu Y; Tao LF; Liu JY; Wang YX; Huang H; Jiang YN; Qian WF
Cancer Med; 2023 Jul; 12(14):15704-15719. PubMed ID: 37306188
[TBL] [Abstract] [Full Text] [Related]
5. Variation in il6st cytokine family function and the potential of IL6 trans-signalling in ERα positive breast cancer cells.
Mosly D; MacLeod K; Moir N; Turnbull A; Sims AH; Langdon SP
Cell Signal; 2023 Mar; 103():110563. PubMed ID: 36565897
[TBL] [Abstract] [Full Text] [Related]
6. Combinational silencing of components involved in JAK/STAT signaling pathway.
Bousoik E; Mahdipoor P; Alhazza A; Montazeri Aliabadi H
Eur J Pharm Sci; 2022 Aug; 175():106233. PubMed ID: 35680032
[TBL] [Abstract] [Full Text] [Related]
7. Quantitative glycoproteomics analysis identifies novel FUT8 targets and signaling networks critical for breast cancer cell invasiveness.
Tu CF; Li FA; Li LH; Yang RB
Breast Cancer Res; 2022 Mar; 24(1):21. PubMed ID: 35303925
[TBL] [Abstract] [Full Text] [Related]
8. The Role of redo-Sentinel Lymph Node Biopsy in Patients With Prior Ipsilateral breast cancer Surgery.
Macnab MF; Slater G; Fuller M; Elsberger B; Lovell L; Staff RT; Masannat YA
Clin Breast Cancer; 2022 Jul; 22(5):e674-e679. PubMed ID: 35279407
[TBL] [Abstract] [Full Text] [Related]
9. IL-6 Cytokine Family: A Putative Target for breast cancer Prevention and Treatment.
Felcher CM; Bogni ES; Kordon EC
Int J Mol Sci; 2022 Feb; 23(3):. PubMed ID: 35163731
[TBL] [Abstract] [Full Text] [Related]
10. gp130 Cytokines Activate Novel Signaling Pathways and Alter Bone Dissemination in ER+ breast cancer Cells.
Omokehinde T; Jotte A; Johnson RW
J Bone Miner Res; 2022 Feb; 37(2):185-201. PubMed ID: 34477239
[TBL] [Abstract] [Full Text] [Related]
11. Bioinformatics Analysis Identifies il6st as a Potential Tumor Suppressor Gene for Triple-Negative breast cancer.
Jia R; Weng Y; Li Z; Liang W; Ji Y; Liang Y; Ning P
Reprod Sci; 2021 Aug; 28(8):2331-2341. PubMed ID: 33650093
[TBL] [Abstract] [Full Text] [Related]
12. Down-regulation of gp130 signaling sensitizes bladder cancer to cisplatin by impairing Ku70 DNA repair signaling and promoting apoptosis.
He S; Li G; Schätzlein AG; Humphrey PA; Weiss RM; Uchegbu IF; Martin DT
Cell Signal; 2021 May; 81():109931. PubMed ID: 33529758
[TBL] [Abstract] [Full Text] [Related]
13. Interleukin-6 trans-signaling is a candidate mechanism to drive progression of human DCCs during clinical latency.
Werner-Klein M; Grujovic A; Irlbeck C; Obradović M; Hoffmann M; Koerkel-Qu H; Lu X; Treitschke S; Köstler C; Botteron C; Weidele K; Werno C; Polzer B; Kirsch S; Gužvić M; Warfsmann J; Honarnejad K; Czyz Z; Feliciello G; Blochberger I; Grunewald S; Schneider E; Haunschild G; Patwary N; Guetter S; Huber S; Rack B; Harbeck N; Buchholz S; Rümmele P; Heine N; Rose-John S; Klein CA
Nat Commun; 2020 Oct; 11(1):4977. PubMed ID: 33020483
[TBL] [Abstract] [Full Text] [Related]
14. Tumors associated with radiotherapy: a case series.
Garcia M; Hernandez DL; Mendoza S; Buelvas N; Alvarez A; Esguerra J; Díaz S
J Med Case Rep; 2020 Oct; 14(1):179. PubMed ID: 33019945
[TBL] [Abstract] [Full Text] [Related]
15. IL-6 and Soluble Receptors in Overweight and Obese African American Women With and Without breast cancer.
Griffith KA; Ryan AS
Biol Res Nurs; 2021 Apr; 23(2):218-222. PubMed ID: 32748635
[TBL] [Abstract] [Full Text] [Related]
16. Coinhibition of S1PR1 and gp130 by siRNA-loaded alginate-conjugated trimethyl chitosan nanoparticles robustly blocks development of cancer cells.
Rostami N; Nikkhoo A; Khazaei-Poul Y; Farhadi S; Sadat Haeri M; Moghadaszadeh Ardebili S; Aghaei Vanda N; Atyabi F; Namdar A; Baghaei M; Haghnavaz N; Kazemi T; Yousefi M; Ghalamfarsa G; Sabz G; Jadidi-Niaragh F
J Cell Physiol; 2020 Dec; 235(12):9702-9717. PubMed ID: 32424937
[TBL] [Abstract] [Full Text] [Related]
17. Functional return after implant-based breast reconstruction: A prospective study of objective and patient-reported outcomes.
Patel AU; Day SJ; Pencek M; Roussel LO; Christiano JG; Punekar IR; Koltz PF; Langstein HN
J Plast Reconstr Aesthet Surg; 2020 May; 73(5):850-855. PubMed ID: 31973982
[TBL] [Abstract] [Full Text] [Related]
18. miR-188-5p suppresses cellular proliferation and migration via il6st: A potential noninvasive diagnostic biomarker for breast cancer.
Wang M; Zhang H; Yang F; Qiu R; Zhao X; Gong Z; Yu W; Zhou B; Shen B; Zhu W
J Cell Physiol; 2020 May; 235(5):4890-4901. PubMed ID: 31650530
[TBL] [Abstract] [Full Text] [Related]
19. Inhibition of Tyrosine-Phosphorylated STAT3 in Human breast and Lung cancer Cells by Manuka Honey is Mediated by Selective Antagonism of the IL-6 Receptor.
Aryappalli P; Shabbiri K; Masad RJ; Al-Marri RH; Haneefa SM; Mohamed YA; Arafat K; Attoub S; Cabral-Marques O; Ramadi KB; Fernandez-Cabezudo MJ; Al-Ramadi BK
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31491838
[TBL] [Abstract] [Full Text] [Related]
20. Metabolically activated adipose tissue macrophages link obesity to triple-negative breast cancer.
Tiwari P; Blank A; Cui C; Schoenfelt KQ; Zhou G; Xu Y; Khramtsova G; Olopade F; Shah AM; Khan SA; Rosner MR; Becker L
J Exp Med; 2019 Jun; 216(6):1345-1358. PubMed ID: 31053611
[TBL] [Abstract] [Full Text] [Related]
[Next]
